BridgeMD
New treatment option for Alcohol Use Disorder (AUD)
Official title Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder
ClinicalTrials.gov ID: NCT07071779
What this study is testing
- What it's testing
- Substance misuse is one of the most common risk factors for health problems and premature death among adolescents and young adults worldwide. Although there are effective treatments for substance use disorder (SUD), there is still a need to further improve their effectiveness and make them easier to access.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 35
You may be able to join if
- Age 14 - 35 years
- Alcohol use disorder identification test (AUDIT) ≥ 7 or Drug Use Identification Test (DUDIT) ≥ 8
- Currently undergoing outpatient treatment or online counselling in one of 7 specialized treatment settings
- Sufficient German language skills
- Informed Consent as documented by signature
You likely can't join if
- Other severe substance use (except nicotine and cannabis) determined by the cut-off value ≥ 25 in the drug use disorder identification test (DUDIT)
- Current medical conditions excluding participation
- Inability to read and understand the participant's information
- Enrolment of the investigator, his/her family members, employees, and other dependent persons Additional exclusion criteria for...
- Current medication affecting EEG (e.g., benzodiazepines)
- Other severe substance use determined by the cut-off value ≥ 25 in the DUDIT (except nicotine)
See the full eligibility criteria
- Age 14 - 35 years
- Alcohol use disorder identification test (AUDIT) ≥ 7 or Drug Use Identification Test (DUDIT) ≥ 8
- Currently undergoing outpatient treatment or online counselling in one of 7 specialized treatment settings
- Sufficient German language skills
- Informed Consent as documented by signature
- Owner of a smartphone with internet access
- Other severe substance use (except nicotine and cannabis) determined by the cut-off value ≥ 25 in the drug use disorder identification test (DUDIT)
- Current medical conditions excluding participation
- Inability to read and understand the participant's information
- Enrolment of the investigator, his/her family members, employees, and other dependent persons Additional exclusion criteria for Electroencephalography (EEG)-substudy:
- Current medication affecting EEG (e.g., benzodiazepines)
- Other severe substance use determined by the cut-off value ≥ 25 in the DUDIT (except nicotine)
- History of epilepsy
- Cochlea implant
The study team makes the final eligibility decision.
Where it's taking place
- Bern, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bern, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.